A review of the key issues associated with the commercialization of biobanks
J Law Biosci
.
2014 Feb 25;1(1):94-110.
doi: 10.1093/jlb/lst004.
eCollection 2014 Mar.
Authors
Timothy Caulfield
,
Sarah Burningham
,
Yann Joly
,
Zubin Master
,
Mahsa Shabani
,
Pascal Borry
,
Allan Becker
,
Michael Burgess
,
Kathryn Calder
,
Christine Critchley
,
Kelly Edwards
,
Stephanie M Fullerton
,
Herbert Gottweis
,
Robyn Hyde-Lay
,
Judy Illes
,
Rosario Isasi
,
Kazuto Kato
,
Jane Kaye
,
Bartha Knoppers
,
John Lynch
,
Amy McGuire
,
Eric Meslin
,
Dianne Nicol
,
Kieran O'Doherty
,
Ubaka Ogbogu
,
Margaret Otlowski
,
Daryl Pullman
,
Nola Ries
,
Chris Scott
,
Malcolm Sears
,
Helen Wallace
,
Ma'n H Zawati
PMID:
27774156
PMCID:
PMC5033518
DOI:
10.1093/jlb/lst004
No abstract available
Grants and funding
R01 DC002012/DC/NIDCD NIH HHS/United States
UL1 TR001425/TR/NCATS NIH HHS/United States